Correlation Between Terns Pharmaceuticals and Arcutis Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Arcutis Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Arcutis Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Arcutis Biotherapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Arcutis Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Arcutis Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Arcutis Biotherapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Arcutis Biotherapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Terns and Arcutis is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Arcutis Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcutis Biotherapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Arcutis Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcutis Biotherapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Arcutis Biotherapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Arcutis Biotherapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Arcutis Biotherapeutics. In addition to that, Terns Pharmaceuticals is 1.0 times more volatile than Arcutis Biotherapeutics. It trades about -0.3 of its total potential returns per unit of risk. Arcutis Biotherapeutics is currently generating about -0.1 per unit of volatility. If you would invest 1,462 in Arcutis Biotherapeutics on November 4, 2024 and sell it today you would lose (138.00) from holding Arcutis Biotherapeutics or give up 9.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Arcutis Biotherapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Arcutis Biotherapeutics |
Terns Pharmaceuticals and Arcutis Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Arcutis Biotherapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Arcutis Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Arcutis Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcutis Biotherapeutics will offset losses from the drop in Arcutis Biotherapeutics' long position.| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
| Arcutis Biotherapeutics vs. Terns Pharmaceuticals | Arcutis Biotherapeutics vs. Amylyx Pharmaceuticals | Arcutis Biotherapeutics vs. Acumen Pharmaceuticals | Arcutis Biotherapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |